ClinicalTrials.gov record
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov ID: NCT00624286
Public ClinicalTrials.gov record NCT00624286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Indacaterol (150 μg o.d.) in Patients With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study was designed to provide 12 weeks efficacy and safety data of the 150 μg once-daily (od) dose of indacaterol in chronic obstructive pulmonary disease (COPD).
Study identification
- NCT ID
- NCT00624286
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 416 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2008 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Jul 2008 (Actual)
- Last update posted
- Aug 18, 2011
2008
United States locations
- U.S. sites
- 118
- U.S. states
- 37
- U.S. cities
- 108
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Anniston | Alabama | 36207-5710 | — |
| Novartis Investigative Site | Birmingham | Alabama | 35209-6870 | — |
| Novartis Investigative Site | Jasper | Alabama | 35501 | — |
| Novartis Investigative Site | Mobile | Alabama | 36608-6705 | — |
| Novartis Investigator Site | Glendale | Arizona | 85306 | — |
| Novartis Investigative Site | Phoenix | Arizona | 85006-2611 | — |
| Novartis Investigative Site | Phoenix | Arizona | 85013-4232 | — |
| Novartis Investigative Site | Tucson | Arizona | 85712 | — |
| Novartis Investigative Site | Tucson | Arizona | 85723 | — |
| Novartis Investigative Site | Pine Bluff | Arkansas | 71603 | — |
| Novartis Investigative Site | Buena Park | California | 90620 | — |
| Novartis Investigative Site | Encinitas | California | 92024-1332 | — |
| Novartis Investigative Site | Fresno | California | 93710 | — |
| Novartis Investigative Site | Fullerton | California | 92835 | — |
| Novartis Investigative Site | Los Angeles | California | 90048 | — |
| Novartis Investigative Site | Orange | California | 92869 | — |
| Novartis Investigative Site | Palmdale | California | 93551-1411 | — |
| Novartis Investigative Site | Riverside | California | 92506 | — |
| Novartis Investigative Site | San Jose | California | 95117 | — |
| Novartis Investigative Site | San Mateo | California | 94401 | — |
| Novartis Investigative Site | Stockton | California | 95207 | — |
| Novartis Investigative Site | Torrance | California | 90503 | — |
| Novartis Investigative Site | Vista | California | 92083 | — |
| Novartis Investigative Site | Walnut Creek | California | 94598 | — |
| Novartis Investigative Site | Fort Collins | Colorado | 80528-3400 | — |
| Novartis Investigative Site | Golden | Colorado | 80401 | — |
| Novartis Investigator Site | Wheat Ridge | Colorado | 80033-4300 | — |
| Novartis Investigative Site | Newark | Delaware | 19713 | — |
| Novartis Investigative Site | Clearwater | Florida | 33765 | — |
| Novartis Investigative Site | Largo | Florida | 33770-2335 | — |
| Novartis Investigative Site | Ocala | Florida | 34471 | — |
| Novartis Investigative Site | Pensacola | Florida | 32503 | — |
| Novartis Investigative Site | Pensacola | Florida | 32504-8756 | — |
| Novartis Investigative Site | Pensacola | Florida | 32504 | — |
| Novartis Investigative Site | Rockledge | Florida | 32955 | — |
| Novartis Investigator Site | Sarasota | Florida | 34233-1272 | — |
| Novartis Investigative Site | South Miami | Florida | 33143 | — |
| Novartis Investigative Site | Tamarac | Florida | 33321 | — |
| Novartis Investigative Site | Tampa | Florida | 33603 | — |
| Novartis Investigative Site | Zephyrhills | Florida | 33542-7505 | — |
| Novartis Investigative Site | Atlanta | Georgia | 30342 | — |
| Novartis Investigative Site | Austell | Georgia | 30106-1110 | — |
| Novartis Investigative Site | Normal | Illinois | 61761 | — |
| Novartis Investigative Site | O'Fallon | Illinois | 62269 | — |
| Novartis Investigative Site | River Forest | Illinois | 60305 | — |
| Novartis Investigative Site | Indianapolis | Indiana | 46285 | — |
| Novartis Investigative Site | Ames | Iowa | 50010 | — |
| Novartis Investigative Site | Iowa City | Iowa | 52240 | — |
| Novartis Investigative Site | Shawnee | Kansas | 66216-1800 | — |
| Novartis Investigative Site | Crescent Springs | Kentucky | 41017 | — |
| Novartis Investigative Site | Lexington | Kentucky | 40504 | — |
| Novartis Investigative Site | Madisonville | Kentucky | 42431 | — |
| Novartis Investigative Site | Metairie | Louisiana | 70006-4225 | — |
| Novartis Investigative Site | Opelousas | Louisiana | 70570 | — |
| Novartis Investigative Site | Slidell | Louisiana | 70458 | — |
| Novartis Investigative Site | Worcester | Massachusetts | 01605 | — |
| Novartis Investigative Site | Ann Arbor | Michigan | 48105-9755 | — |
| Novartis Investigative Site | Clarkston | Michigan | 48346 | — |
| Novartis Investigative Site | Flint | Michigan | 58532 | — |
| Novartis Investigative Site | Livonia | Michigan | 48152 | — |
| Novartis Investigative Site | Troy | Michigan | 48085 | — |
| Novartis Investigator Site | Edina | Minnesota | 55435 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55407 | — |
| Novartis Investigative Site | Saint Charles | Missouri | 63301-2847 | — |
| Novartis Investigator Site | St Louis | Missouri | 63141 | — |
| Novartis Investigative Site | Kalispell | Montana | 59901 | — |
| Novartis Investigative Site | Missoula | Montana | 59808 | — |
| Novartis Investigative Site | Lincoln | Nebraska | 68510 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68114-3570 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigative Site | Henderson | Nevada | 89014 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89102-4508 | — |
| Novartis Investigative Site | Cherry Hill | New Jersey | 08003 | — |
| Novartis Investigative Site | Summit | New Jersey | 07901 | — |
| Novartis Investigative Site | Cortland | New York | 13045 | — |
| Novartis Investigative Site | Rochester | New York | 14618 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28277 | — |
| Novartis Investigative Site | High Point | North Carolina | 27262-4320 | — |
| Novartis Investigative Site | Shelby | North Carolina | 28150 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45227 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45231 | — |
| Novartis Investigator Site | Cincinnati | Ohio | 45242 | — |
| Novartis Investigative Site | Columbus | Ohio | 43213 | — |
| Novartis Investigative Site | Columbus | Ohio | 43215 | — |
| Novartis Investigative Site | Marion | Ohio | 43302 | — |
| Novartis Investigative Site | Thornville | Ohio | 43076-8010 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73112 | — |
| Novartis Investigative Site | Tulsa | Oklahoma | 74135-2920 | — |
| Novartis Investigative Site | Eugene | Oregon | 97404 | — |
| Novartis Investigative Site | Medford | Oregon | 97504-9741 | — |
| Novartis Investigative Site | Portland | Oregon | 97213 | — |
| Novartis Investigative Site | Erie | Pennsylvania | 15608 | — |
| Novartis Investigative Site | Homestead | Pennsylvania | 15120 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15243-1800 | — |
| Novartis Investigative Site | Cumberland | Rhode Island | 02864 | — |
| Novartis Investigative Site | Charleston | South Carolina | 29412 | — |
| Novartis Investigative Site | Gaffney | South Carolina | 29340 | — |
| Novartis Investigative Site | Greenville | South Carolina | 29615 | — |
| Novartis Investigative Site | North Charleston | South Carolina | 29406-9167 | — |
| Novartis Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Novartis Investigative Site | Union | South Carolina | 29379 | — |
| Novartis Investigative Site | Johnson City | Tennessee | 37601 | — |
| Novartis Investigative Site | Amarillo | Texas | 79106 | — |
| Novartis Investigative Site | El Paso | Texas | 79902-5107 | — |
| Novartis Investigative Site | Fort Worth | Texas | 76104-4185 | — |
| Novartis Investigative Site | New Braunfels | Texas | 78130-6113 | — |
| Novartis Investigative Site | San Antonio | Texas | 78229 | — |
| Novartis Investigative Site | Payson | Utah | 84651 | — |
| Novartis Investigative Site | Abingdon | Virginia | 24210-2921 | — |
| Novartis Investigative Site | Lynchburg | Virginia | 24501 | — |
| Novartis Investigative Site | Richmond | Virginia | 23229 | — |
| Novartis Investigative Site | Richmond | Virginia | 23298 | — |
| Novartis Investigative Site | Spokane | Washington | 99201 | — |
| Novartis Investigative Site | Spokane Valley | Washington | 99216-1092 | — |
| Novartis Investigative Site | Tacoma | Washington | 98405 | — |
| Novartis Investigative Site | Morgantown | West Virginia | 26505-2713 | — |
| Novartis Investigative Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00624286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2011 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00624286 live on ClinicalTrials.gov.